// App-Quantinova.ai

8397 : MRI Use in MS Clinical Practice: Results of the 2022 CMSC Survey

Researchers

Presenter

  • Anthony Traboulsee

Principal Investigators

  • Lori Saslow

  • Mike Wattjes

  • Alex Rovira

  • Jiwon Oh

  • Daniel Reich

  • Scott D. Newsome

  • Mara Rocca

  • Jaume Sastre-Garriga

  • June Halper

  • Frederik Barkhof

  • David KB Li

Medical Centers

  • Consortium of MS Centers (CMSC), Hackensack, NJ

  • Medicine, Division of Neurology, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada

  • Multiple Sclerosis Centre of Catalonia (Cemcat), Department of Neurology/Neuroimmunology, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain

  • Dept. of Neurology, Johns Hopkins School of Medicine, Baltimore, MD

  • Section of Neuroradiology, Department of Radiology, Hospital Universitari Vall d'Hebron, Autonomous University of Barcelona, Barcelona, Spain

  • Translational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health Bethesda MD United States

  • Department of Diagnostic and Interventional Neuroradiology, Hannover Medical School, Hannover, Germany

  • Institute of Healthcare Engineering, UCL, London, United Kingdom

  • Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada

  • Vita-Salute San Raffaele University, Milan, Italy

Locations

  • Italy

  • United States

  • Spain

  • Canada

  • United Kingdom

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved